MELISSA TAYLOR: Open Payments
NPI 1790118156 · REHOBOTH BEACH, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,286 in 37 payments from 12 companies in 2025. Trend: 2023 $1,064 · 2024 $531 · 2025 $1,286
Food & beverage: $1,147Education: $139
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $540 |
| ABBVIE INC. | 9 | $175 |
| Lilly USA, LLC | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $117 |
| PFIZER INC. | 4 | $75 |
| GENZYME CORPORATION | 1 | $67 |
| Novartis Pharmaceuticals Corporation | 3 | $51 |
| Amgen Inc. | 2 | $38 |
| Kerecis Limited | 1 | $30 |
| Incyte Corporation | 1 | $25 |
Products named: TREMFYA, EBGLYSS, SKYRIZI, Sotyktu, DUPIXENT, CIBINQO, RINVOQ, OTEZLA.
Industry payments across DE — which companies pay providers there.
